The efficacy of high-dose nasal steroid spray in postoperative management of nasal polyps : A randomized controlled trial

Phase 4

Recruiting

• Conditions: Postoperative nasal polyp; Nasal polyps, nasal steroid spray, functional endoscopic sinus surgery, high-dose; mometasone furoate, recurrent nasal polyposis

• Registration Number: TCTR20211225001
• Lead Sponsor: Sirinkarn Sookdee

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-12-24
• Study Start: 2021-12-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Postoperative nasal polyp

Exclusion Criteria

1. no nasal tumor 2.no history of previous nasal surgery 3. no active nasal or paranasal sinus infection 5. no history of systemic steroid use within 1 month 6. no history of steroid allergy/ immunocompromised host/ DM 7. no pregnancy or breast feeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Grading of nasal polyps week 1, 2, 4, 12, 24 Size of nasal polyps

Secondary Outcome Measures

Name	Time	Method
Symptom score week 1, 2, 4, 12, 24 Questionaire